These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22677938)

  • 21. Pharmacotherapy to Enhance Cognitive and Motor Recovery Following Stroke.
    Beristain X; Golombievski E
    Drugs Aging; 2015 Oct; 32(10):765-72. PubMed ID: 26423272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurostimulant medication usage during stroke rehabilitation: the Post-Stroke Rehabilitation Outcomes Project (PSROP).
    Zorowitz RD; Smout RJ; Gassaway JA; Horn SD
    Top Stroke Rehabil; 2005; 12(4):28-36. PubMed ID: 16698735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amphetamine and other pharmacological agents in human and animal studies of recovery from stroke.
    Walker-Batson D; Mehta J; Smith P; Johnson M
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():225-30. PubMed ID: 25896190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probably role of citicoline in stroke rehabilitation: review of the literature.
    Secades JJ
    Rev Neurol; 2012 Feb; 54(3):173-9. PubMed ID: 22278894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination treatment of low-frequency rTMS and occupational therapy with levodopa administration: an intensive neurorehabilitative approach for upper limb hemiparesis after stroke.
    Kakuda W; Abo M; Kobayashi K; Momosaki R; Yokoi A; Fukuda A; Ito H; Tominaga A
    Int J Neurosci; 2011 Jul; 121(7):373-8. PubMed ID: 21426243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy in restorative neurology.
    Liepert J
    Curr Opin Neurol; 2008 Dec; 21(6):639-43. PubMed ID: 18989105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital rates of thrombolysis for acute ischemic stroke: the influence of organizational culture.
    van Wijngaarden JD; Dirks M; Huijsman R; Niessen LW; Fabbricotti IN; Dippel DW;
    Stroke; 2009 Oct; 40(10):3390-2. PubMed ID: 19713539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opening the black box of stroke rehabilitation with clinical practice improvement methodology.
    Conroy BE; Hatfield B; Nichols D
    Top Stroke Rehabil; 2005; 12(2):36-48. PubMed ID: 15940583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pay for performance in rehabilitation after stroke - results of a pilot project 2001-2008].
    Gerdes N; Funke UN; Schüwer U; Kunze H; Walle E; Kleinfeld A; Reiland M; Jäckel WH
    Rehabilitation (Stuttg); 2009 Aug; 48(4):190-201. PubMed ID: 19688657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Pleurotus eryngii stalk residue on the oxidative status and meat quality of broiler chickens.
    Lee TT; Ciou JY; Chiang CJ; Chao YP; Yu B
    J Agric Food Chem; 2012 Nov; 60(44):11157-63. PubMed ID: 23075076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing recovery after stroke with noradrenergic pharmacotherapy: a new frontier?
    Gladstone DJ; Black SE
    Can J Neurol Sci; 2000 May; 27(2):97-105. PubMed ID: 10830340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.
    Yang X; Li Z; Zhao X; Wang C; Liu L; Wang C; Pan Y; Li H; Wang D; Hart RG; Wang Y; Wang Y;
    Stroke; 2016 Feb; 47(2):464-70. PubMed ID: 26696643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depression and functional outcome after stroke: the effect of antidepressant therapy on functional recovery.
    Bilge C; Koçer E; Koçer A; Türk Börü U
    Eur J Phys Rehabil Med; 2008 Mar; 44(1):13-8. PubMed ID: 18385623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors contributing to practice variation in post-stroke rehabilitation.
    Lee AJ; Huber JH; Stason WB
    Health Serv Res; 1997 Jun; 32(2):197-221; discussion 223-7. PubMed ID: 9180616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anxiety and depressive symptoms after stroke in 9 rehabilitation centers.
    Masskulpan P; Riewthong K; Dajpratham P; Kuptniratsaikul V
    J Med Assoc Thai; 2008 Oct; 91(10):1595-602. PubMed ID: 18972905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of the probability of reaching mobility independence at discharge from a rehabilitation hospital in nonwalking early ischemic stroke patients: a multivariate study.
    Paolucci S; Bragoni M; Coiro P; De Angelis D; Fusco FR; Morelli D; Venturiero V; Pratesi L
    Cerebrovasc Dis; 2008; 26(1):16-22. PubMed ID: 18511867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amphetamine fails to facilitate motor performance and to enhance motor recovery among stroke patients with mild arm paresis: interim analysis and termination of a double blind, randomised, placebo-controlled trial.
    Platz T; Kim IH; Engel U; Pinkowski C; Eickhof C; Kutzner M
    Restor Neurol Neurosci; 2005; 23(5-6):271-80. PubMed ID: 16477089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence-based practice and setting basic standards for stroke rehabilitation in Canada.
    Teasell R; Foley N; Bhogal S; Bagg S; Jutai J
    Top Stroke Rehabil; 2006; 13(3):59-65. PubMed ID: 16987792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological Enhancement of Stroke Rehabilitation.
    Abe H; Jitsuki S; Takahashi T
    Stroke; 2019 Nov; 50(11):3323-3329. PubMed ID: 31594462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.